Business
CSL rules out making homegrown mRNA COVID vaccine – Sydney Morning Herald
The local biotech giant’s boss, Paul Perreault, says mRNA technology will be used to develop a treatment against flu instead…
The Australian Shareholders Association also whether the board had considered intervening in Mr Perreaults 2021 pay, after he received $61 million in total remuneration last year despite total shareholder return being zero. Mr McNamee said this total came…
Continue Reading
-
General21 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Noosa News23 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business21 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General23 hours agoToo skewed, too gentlemanly | The Spectator Australia